ArticleImmunity, inflammation and disease2025

Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID-19.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.